How Cryotherapy Works for Prostate Cancer
Freezing treatment for prostate cancer, also called cryotherapy or cryoablation, uses extreme cold to destroy malignant tissue inside the gland. During the procedure, a surgeon inserts several thin probes through the perineum—the skin between the scrotum and rectum—into the prostate. Ultrasound imaging guides placement, and a freezing gas, typically argon, flows through the probes to form ice balls that engulf the target tissue. A warming catheter protects the urethra and rectum while the surrounding cells are destroyed. The frozen tissue eventually shrinks and is absorbed by the body over weeks to months.
More from this site
Keep reading the latest coverage
Cryotherapy can be performed as an focal treatment, targeting only the visible tumor, or as a whole-gland treatment when the cancer is more widespread. The approach depends on tumor size, location, Gleason score, and whether the cancer is localized or has recurred after prior therapy.
Who Is a Candidate for Freezing Treatment
Men with localized prostate cancer who are not ideal candidates for surgery or radiation may be offered cryotherapy. Common scenarios include patients who have had a previous round of radiation therapy and face a recurrence, those with medical conditions that make general anesthesia or lengthy surgery risky, and individuals who prefer a minimally invasive option with a shorter recovery timeline. Focal cryotherapy is increasingly considered for men with low- to intermediate-risk disease confined to a single region of the prostate.
Because cryotherapy does not remove the prostate, pathologists cannot examine the entire gland for cancer spread the way they can after a radical prostatectomy. This limits the ability to confirm clear margins, and doctors rely heavily on pre-treatment imaging and biopsy mapping.
The Procedure and Recovery Timeline
Most cryotherapy sessions last one to two hours and are done under general or spinal anesthesia. Patients typically go home the same day or stay overnight for observation. A catheter remains in place for about one to two weeks while the urethra heals from the cold exposure. Urinary leakage, urgency, and discomfort are common in the first weeks, and most men regain continence within three to six months.
Erectile function can be affected because the nerves responsible for erections run along the prostate capsule. The risk depends on whether the neurovascular bundles were spared, the patient's baseline function, and whether focal or whole-gland treatment was used. Doctors may prescribe medications such as PDE5 inhibitors or refer patients to rehabilitation programs to support recovery.
Comparing Cryotherapy to Surgery and Radiation
Freezing treatment occupies a distinct position among local therapies. Unlike surgery, it does not involve a large incision or removal of the gland. Compared with radiation, it can often be repeated if cancer returns, and it avoids some of the long-term bowel side effects associated with beams or seeds.
| Attribute | Cryotherapy | Radical Prostatectomy | Radiation Therapy |
|---|---|---|---|
| Invasiveness | Minimally invasive, percutaneous | Surgical removal of prostate | Non-invasive, external or implanted seeds |
| Typical Recovery | Days to weeks | Weeks to months | Weeks for acute side effects |
| Repeatability | Yes | Limited | Limited if prior dose reached |
| Key Risks | Urinary, erectile, rectal injury | Urinary incontinence, erectile dysfunction | Bowel irritation, urinary irritation |
| Best Suited For | Recurrence after radiation, select localized cases | Organ-confined disease, life expectancy over 10 years | Localized disease, older or comorbid patients |
Effectiveness and Long-Term Outcomes
Long-term data on cryotherapy continue to grow. Studies show that biochemical recurrence rates, measured by PSA levels, are comparable to surgery and radiation for carefully selected patients. Focal cryotherapy has demonstrated promising cancer control with potentially lower side-effect profiles, though it is not yet the standard first-line treatment for all men.
Because cryotherapy leaves the prostate in place, monitoring continues with regular PSA tests and, when needed, follow-up biopsies. Patients should discuss with their urologist how the results will be interpreted and what thresholds would trigger additional treatment.
Side Effects and Managing Expectations
Common short-term effects include blood in the urine, scrotal swelling, and mild rectal discomfort. Serious complications such as fistulas or urethral strictures are uncommon but possible. Sexual side effects vary widely, and many men retain function when focal techniques are used and baseline health is good.
Patients considering freezing treatment should ask their care team about the surgeon's specific experience, complication rates, and the plan for preserving urinary and sexual function. Choosing a center with a high volume of cryotherapy cases and a multidisciplinary support team improves the likelihood of a smooth recovery and durable cancer control.